Read + Share
Amedeo Smart
Independent Medical Education
Thomas MK, Nikooienejad A, Bray R, Cui X, et al. Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes. J Clin Endocrinol Metab 2020 Nov 25. pii: 6000489. doi: 10.1210.PMID: 33236115
Email
LinkedIn
Facebook
Twitter
Privacy Policy